At present, no collaboration has been discussed with Roche management, although we hope that over time we will be able to explore areas of collaboration.

Market growth in 2006 will slow down somewhat. I expect that we will be able to continue to gain market share.

Our plan is to turn around the Chiron vaccines business, which will require investments in R&D and manufacturing to increase quality and capacity,

Our customers have asked us for a holistic management tool to control all real-time collaboration and keep it highly available, compliant and secure.

Our customers have asked us for a holistic management tool to control all real-time collaboration and keep it highly available, compliant, and secure. They understand the requirements for messaging security and a number of them are already using our solutions in combination with Symantec solutions.

There is only now. And look! How rich we are in it.